Literature DB >> 27868136

Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid.

Judith Engmann1, Urda Rüdrich, Georg Behrens, Eleni Papakonstantinou, Manuela Gehring, Alexander Kapp, Ulrike Raap.   

Abstract

Bullous pemphigoid (BP) is an autoimmune blistering skin disease that is more common in elderly individuals. The aim of this study was to determine the functional activity of eosinophils in patients with BP compared with healthy donors. Blood, skin and blister-derived eosinophils were strongly activated in patients with BP, seen by increased surface expression of CD69 compared with controls. CD11b was also increased in BP blood eosinophils, which may explain the striking accumulation of eosinophils in BP (1×106 per ml blister fluid). Furthermore, CCL26 was expressed by activated eosinophils in BP skin and in blister fluid. BP eosinophils also released IL-6, IL-8 and IL-1α in BP blister fluids. Apoptosis in cultivated BP eosinophils was increased and accompanied by enhanced surface externalization of CD95. Caspase 3 positive eosinophils in lesional BP skin and blister fluid also showed the initiation of apoptosis. These results reveal novel pathophysiological aspects of BP, with a strong activation pattern and increased apoptosis of eosinophils in the peripheral blood, skin and blister fluids.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27868136     DOI: 10.2340/00015555-2581

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  8 in total

Review 1.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

Review 2.  Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Mansour Seaf; Giancarlo Marone; Francesca Levi-Schaffer; Gianni Marone
Journal:  Front Med (Lausanne)       Date:  2017-07-24

Review 3.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

Review 4.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 5.  Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.

Authors:  Karim Chouchane; Giovanni Di Zenzo; Dario Pitocco; Laura Calabrese; Clara De Simone
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

6.  Potent Anti-Inflammatory Effects of Tetracyclines on Human Eosinophils.

Authors:  Manuela Gehring; Dorothea Wieczorek; Alexander Kapp; Bettina Wedi
Journal:  Front Allergy       Date:  2021-10-04

Review 7.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10

8.  IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients.

Authors:  A Lamberts; N Kotnik; G F H Diercks; J M Meijer; G Di Zenzo; H H Pas; M F Jonkman; B F Gibbs; U Raap; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-11-17       Impact factor: 6.166

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.